FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2991054936> ?p ?o ?g. }

• W2991054936 endingPage "9467" @default.
• W2991054936 startingPage "9453" @default.
• W2991054936 abstract "Ovarian cancer is a common malignancy in the female reproductive system with a high mortality rate. The most important reason is multidrug resistance (MDR) of cancer chemotherapy. To reduce side effects, reverse resistance and improve efficacy for the treatment of ovarian cancer, a core-shell polymeric nanoparticle-mediated curcumin and paclitaxel co-delivery platform was designed.Nuclear magnetic resonance confirmed the successful grafting of polyethylenimine (PEI) and stearic acid (SA) (PEI-SA), which is designed as a mother core for transport carrier. Then, PEI-SA was modified with hyaluronic acid (HA) and physicochemical properties were examined. To understand the regulatory mechanism of resistance and measure the anti-tumor efficacy of the treatments, cytotoxicity assay, cellular uptake, P-glycoprotein (P-gp) expression and migration experiment of ovarian cancer cells were performed. In addition, adverse reactions of nanoformulation to the reproductive system were examined.HA-modified drug-loaded PEI-SA had a narrow size of about 189 nm in diameters, and the particle size was suitable for endocytosis. The nanocarrier could target specifically to CD44 receptor on the ovarian cancer cell membrane. Co-delivery of curcumin and paclitaxel by the nanocarriers exerts synergistic anti-ovarian cancer effects on chemosensitive human ovarian cancer cells (SKOV3) and multi-drug resistant variant (SKOV3-TR30) in vitro, and it also shows a good anti-tumor effect in ovarian tumor-bearing nude mice. The mechanism of reversing drug resistance may be that the nanoparticles inhibit the efflux of P-gp, inhibit the migration of tumor cells, and curcumin synergistically reverses the resistance of PTX to increase antitumor activity. It is worth noting that the treatment did not cause significant toxicity to the uterus and ovaries with the observation of macroscopic and microscopic.This special structure of targeting nanoparticles co-delivery with the curcumin and paclitaxel can increase the anti-tumor efficacy without increasing the adverse reactions as a promising strategy for therapy ovarian cancer." @default.
• W2991054936 created "2019-12-05" @default.
• W2991054936 creator A5002318539 @default.
• W2991054936 creator A5013135220 @default.
• W2991054936 creator A5043243034 @default.
• W2991054936 creator A5056949279 @default.
• W2991054936 creator A5061271427 @default.
• W2991054936 creator A5065625415 @default.
• W2991054936 creator A5071751871 @default.
• W2991054936 creator A5072394625 @default.
• W2991054936 creator A5088562884 @default.
• W2991054936 date "2019-12-01" @default.
• W2991054936 modified "2023-10-01" @default.
• W2991054936 title "<p>Co-Delivery of Curcumin and Paclitaxel by “Core-Shell” Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer</p>" @default.
• W2991054936 cites W2018304270 @default.
• W2991054936 cites W2023135059 @default.
• W2991054936 cites W2156316554 @default.
• W2991054936 cites W2156480768 @default.
• W2991054936 cites W2213822094 @default.
• W2991054936 cites W2229457841 @default.
• W2991054936 cites W2333901123 @default.
• W2991054936 cites W2393147091 @default.
• W2991054936 cites W2625768919 @default.
• W2991054936 cites W2752543711 @default.
• W2991054936 cites W2768999961 @default.
• W2991054936 cites W2791923263 @default.
• W2991054936 cites W2792334962 @default.
• W2991054936 cites W2793171298 @default.
• W2991054936 cites W2793731239 @default.
• W2991054936 cites W2794117155 @default.
• W2991054936 cites W2794612623 @default.
• W2991054936 cites W2795267732 @default.
• W2991054936 cites W2795269248 @default.
• W2991054936 cites W2798090270 @default.
• W2991054936 cites W2800036023 @default.
• W2991054936 cites W2801545490 @default.
• W2991054936 cites W2802252398 @default.
• W2991054936 cites W2803563565 @default.
• W2991054936 cites W2803962479 @default.
• W2991054936 cites W2809850739 @default.
• W2991054936 cites W2884485757 @default.
• W2991054936 cites W2887182956 @default.
• W2991054936 cites W2888732759 @default.
• W2991054936 cites W2889557274 @default.
• W2991054936 cites W2889604231 @default.
• W2991054936 cites W2895897574 @default.
• W2991054936 cites W2896079572 @default.
• W2991054936 cites W2897961739 @default.
• W2991054936 cites W2901015920 @default.
• W2991054936 cites W2901539124 @default.
• W2991054936 cites W2908345915 @default.
• W2991054936 cites W2910346583 @default.
• W2991054936 cites W2912184964 @default.
• W2991054936 cites W2912526870 @default.
• W2991054936 cites W2912707474 @default.
• W2991054936 cites W2913594555 @default.
• W2991054936 cites W2914071247 @default.
• W2991054936 cites W2914157893 @default.
• W2991054936 cites W2915027590 @default.
• W2991054936 cites W2916045508 @default.
• W2991054936 cites W2916816608 @default.
• W2991054936 cites W2919810740 @default.
• W2991054936 cites W2921110822 @default.
• W2991054936 doi "https://doi.org/10.2147/ijn.s224579" @default.
• W2991054936 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6898996" @default.
• W2991054936 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31819443" @default.
• W2991054936 hasPublicationYear "2019" @default.
• W2991054936 type Work @default.
• W2991054936 sameAs 2991054936 @default.
• W2991054936 citedByCount "72" @default.
• W2991054936 countsByYear W29910549362020 @default.
• W2991054936 countsByYear W29910549362021 @default.
• W2991054936 countsByYear W29910549362022 @default.
• W2991054936 countsByYear W29910549362023 @default.
• W2991054936 crossrefType "journal-article" @default.
• W2991054936 hasAuthorship W2991054936A5002318539 @default.
• W2991054936 hasAuthorship W2991054936A5013135220 @default.
• W2991054936 hasAuthorship W2991054936A5043243034 @default.
• W2991054936 hasAuthorship W2991054936A5056949279 @default.
• W2991054936 hasAuthorship W2991054936A5061271427 @default.
• W2991054936 hasAuthorship W2991054936A5065625415 @default.
• W2991054936 hasAuthorship W2991054936A5071751871 @default.
• W2991054936 hasAuthorship W2991054936A5072394625 @default.
• W2991054936 hasAuthorship W2991054936A5088562884 @default.
• W2991054936 hasBestOaLocation W29910549361 @default.
• W2991054936 hasConcept C109316439 @default.
• W2991054936 hasConcept C121608353 @default.
• W2991054936 hasConcept C126322002 @default.
• W2991054936 hasConcept C171250308 @default.
• W2991054936 hasConcept C18150654 @default.
• W2991054936 hasConcept C185592680 @default.
• W2991054936 hasConcept C192562407 @default.
• W2991054936 hasConcept C202751555 @default.
• W2991054936 hasConcept C2777292972 @default.
• W2991054936 hasConcept C2778250585 @default.
• W2991054936 hasConcept C2779820397 @default.
• W2991054936 hasConcept C2780035454 @default.
• W2991054936 hasConcept C2780084626 @default.

• next